CORC

在结果中检索

CORC

浏览/检索结果: 共126条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Investigations of nano-defect morphology and vibrational spectra of swift heavy ion irradiated muscovite mica 会议论文
作者:  
收藏  |  浏览/下载：58/0  |  提交时间：2019/03/27
APPLICATION OF ADAPTIVE ITERATIVE LEARNING CONTROL BASED ON PARTICLE SWARM OPTIMIZATION ALGORITHM IN THE TEMPERATURE CONTROL OF THE BIOGAS POOL 会议论文
作者:  Gu, Q.;  Hao, X. H.;  Pei, T. T.;  Zhang, C. Y.;  Duan, J.
收藏  |  浏览/下载：5/0  |  提交时间：2019/11/15
A Novel Binary Jaya Optimization for Economic/Emission Unit Commitment 会议论文
里约, 2018
作者:  Y. Zhou;  Z. Yang;  Y. Guo;  Q. Niu;  H. Ma
收藏  |  浏览/下载：15/0  |  提交时间：2019/01/31
HER2 amplification is associated with higher tumor mutation burden in breast cancer 会议论文
作者:  Yin, Y.;  Li, W.;  Huang, X.;  Wu, H.;  Zhang, Y.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/04
Extended-Field Intensity Modulated Radiation Therapy (EF-IMRT) and Intra-Cavitary Brachytherapy Combined with Chemotherapy in Cervical Cancer: A Multicenter-Clinical Trial 会议论文
作者:  Zhu, H.;  Hu, K.;  Ma, J.;  Zhang, F.;  Wei, L.
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
A China-manufactured bevacizumab biosimilar, HLX04, matches bevacizumab sourced from China, USA and the European Union 会议论文
作者:  Ding, Y.;  Yu, T.;  Sun, J.;  Wu, M.;  Chen, Q.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Mutation status and targeted therapeutic efficacy of advanced non-small cell lung cancer: A real-world study of NSCLC in China (preCAPTRA-LUNG) 会议论文
作者:  Liang, H.;  Song, X.;  Zhang, Y.;  Zhang, S.;  Li, F.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace